Primary Site >> Colorectal Cancer
Gene >> DEK
| 1. | |||||||||||
| Journal: | Cell Cycle. 2006 Jun;5(11):1202-7. | ||||||||||
| Title: | DEK Expression is controlled by E2F and deregulated in diverse tumor types. | ||||||||||
| Author: | Carro, Maria Stella|Spiga, Fabio Mario|Quarto, Micaela|Di Ninni, Valentina|Volorio, Sara|Alcalay, Myriam|Muller, Heiko | ||||||||||
| PMID: | 16721057 | ||||||||||
| 2. | |||||||||||
| Journal: | J Exp Med. 2011 Feb 14;208(2):295-312. | ||||||||||
| Title: | FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation. | ||||||||||
| Author: | Babaei-Jadidi, Roya|Li, Ningning|Saadeddin, Anas|Spencer-Dene, Bradley|Jandke, Anett|Muhammad, Belal|Ibrahim, ElSayed E|Muraleedharan, Ranjithmenon|Abuzinadah, Mohammed|Davis, Hayley|Lewis, Annabelle|Watson, Susan|Behrens, Axel|Tomlinson, Ian|Nateri, Abdo | ||||||||||
| PMID: | 21282377 | ||||||||||
| 3. | |||||||||||
| Journal: | BMC Cancer. 2013 Jul 31;13:366. | ||||||||||
| Title: | DEK over expression as an independent biomarker for poor prognosis in colorectal cancer. | ||||||||||
| Author: | Lin, Lijuan|Piao, Junjie|Gao, Wenbin|Piao, Yingshi|Jin, Guang|Ma, Yue|Li, Jinzi|Lin, Zhenhua | ||||||||||
| PMID: | 23902796 | ||||||||||
| 4. | |||||||||||
| Journal: | Tohoku J Exp Med. 2014 Mar;232(3):167-76. | ||||||||||
| Title: | Association of sedentary behavior with the expression levels of biomarkers in colorectal cancer: clinical analysis of 228 patients. | ||||||||||
| Author: | Yu, Ting|Lu, Qin|Ou, Xilong|Cao, Dazhong|Yu, Qian | ||||||||||
| PMID: | 24621823 | ||||||||||
| 5. | |||||||||||
| Journal: | PLoS One. 2014 Oct 23;9(10):e111260. | ||||||||||
| Title: | Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer. | ||||||||||
| Author: | Lin, Lijuan|Piao, Junjie|Ma, Yibing|Jin, Tiefeng|Quan, Chengshi|Kong, Jienan|Li, Yulin|Lin, Zhenhua | ||||||||||
| PMID: | 25340858 | ||||||||||
| 6. | |||||||||||
| Journal: | BMC Cancer. 2014 Dec 16;14:965. | ||||||||||
| Title: | DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer. | ||||||||||
| Author: | Martinez-Useros, Javier|Rodriguez-Remirez, Maria|Borrero-Palacios, Aurea|Moreno, Irene|Cebrian, Arancha|Gomez del Pulgar, Teresa|del Puerto-Nevado, Laura|Vega-Bravo, Ricardo|Puime-Otin, Alberto|Perez, Nuria|Zazo, Sandra|Senin, Clara|Fernandez-Acenero, Mar | ||||||||||
| PMID: | 25515240 | ||||||||||
| 7. | |||||||||||
| Journal: | Mol Med Rep. 2018 Jan;17(1):1065-1070. | ||||||||||
| Title: | Epithelialmesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3. | ||||||||||
| Author: | You, Shuping|Guan, Yun|Li, Weihong | ||||||||||
| PMID: | 29115492 | ||||||||||
| 8. | |||||||||||
| Journal: | BMC Cancer. 2018 Feb 6;18(1):144. | ||||||||||
| Title: | The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer. | ||||||||||
| Author: | Martinez-Useros, J|Moreno, I|Fernandez-Acenero, M J|Rodriguez-Remirez, M|Borrero-Palacios, A|Cebrian, A|Gomez Del Pulgar, T|Del Puerto-Nevado, L|Li, W|Puime-Otin, A|Perez, N|Soengas, M S|Garcia-Foncillas, J | ||||||||||
| PMID: | 29409457 | ||||||||||